Published in Neuroscience on May 13, 2011
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model. J Neurochem (2012) 0.79
Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury. J Neurotrauma (2016) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 15.15
Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain (2009) 7.11
Models and mechanisms of hyperalgesia and allodynia. Physiol Rev (2009) 3.96
Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology (2007) 3.10
Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron (2008) 3.01
Cell signaling and the genesis of neuropathic pain. Sci STKE (2004) 2.06
Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res Brain Res Rev (1998) 1.68
Synaptic plasticity and phosphorylation. Pharmacol Ther (2006) 1.58
Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci (2008) 1.36
Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun (2003) 1.32
Loose ligation of the sciatic nerve is associated with TrkB receptor-dependent decreases in KCC2 protein levels in the ipsilateral spinal dorsal horn. Pain (2007) 1.29
Neurotrophin activation of NFAT-dependent transcription contributes to the regulation of pro-nociceptive genes. J Neurochem (2007) 1.10
Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex. Nat Neurosci (2005) 1.00
Calcineurin as a nociceptor modulator. Pain Physician (2009) 0.98
Loose ligation of the sciatic nerve in rats elicits transient up-regulation of Homer1a gene expression in the spinal dorsal horn. Neurosci Lett (2006) 0.92
Localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the hindbrain and spinal cord of the rat. J Comp Neurol (1996) 0.88
Unilateral vestibular deafferentation-induced changes in calcium signaling-related molecules in the rat vestibular nuclear complex. Brain Res (2006) 0.84
Calcineurin contributes to spatial memory impairment induced by rapid eye movement sleep deprivation. Neuroreport (2009) 0.83
Calcineurin and synaptophysin in the human spinal cord of normal individuals and patients with familial dysautonomia. Acta Neuropathol (1990) 0.81
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Archaic African and Asian lineages in the genetic ancestry of modern humans. Am J Hum Genet (1997) 8.63
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
Bone marrow transplantation for sickle cell disease. N Engl J Med (1996) 4.02
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Lancet (1993) 3.84
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet (1998) 3.41
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Relation of cognitive activity to risk of developing Alzheimer disease. Neurology (2007) 3.34
Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect (1993) 3.06
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am (1999) 2.86
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest (1976) 2.70
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
The application of mitochondrial DNA typing to the study of white Caucasian genetic identification. Int J Legal Med (1993) 2.64
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Neurodegenerative basis of age-related cognitive decline. Neurology (2010) 2.41
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med (1998) 2.36
Chronic distress and incidence of mild cognitive impairment. Neurology (2007) 2.33
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis. Science (1967) 2.12
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med (1988) 1.92
Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology (1998) 1.92
Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med (1987) 1.92
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci (2001) 1.86
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood (1997) 1.80
Expression of differentiated functions in hepatoma cell hybrids. I. Tyrosine aminotransferase in hepatoma-fibroblast hybrids. Proc Natl Acad Sci U S A (1971) 1.80
Infection with varicella-zoster virus after marrow transplantation. J Infect Dis (1985) 1.77
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood (1996) 1.77
Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem (1974) 1.74
Human lysosomes can be purified from diploid skin fibroblasts by free-flow electrophoresis. Proc Natl Acad Sci U S A (1980) 1.73
Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant (1993) 1.72
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood (1995) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem (1982) 1.71
Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry (1992) 1.70
Memory complaints are related to Alzheimer disease pathology in older persons. Neurology (2006) 1.67
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Long-term outcome after marrow transplantation for severe aplastic anemia. Blood (1998) 1.63
Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60
A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell. Am J Cardiol (1976) 1.58
Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood (1989) 1.57
Body mass index in older persons is associated with Alzheimer disease pathology. Neurology (2006) 1.55
Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry (2005) 1.55
The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry (2006) 1.55
Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet (1998) 1.53
Influence of cation size and charge on the extrusion of a salt-dependent cruciform. J Mol Biol (1987) 1.49
Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med (1989) 1.47
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med (1983) 1.44
Forensic application of a rapid and quantitative DNA sex test by amplification of the X-Y homologous gene amelogenin. Int J Legal Med (1994) 1.44
Photic sneeze reflex in nephropathic cystinosis. Br J Ophthalmol (1990) 1.42
Education modifies the association of amyloid but not tangles with cognitive function. Neurology (2005) 1.42
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation (2001) 1.41
Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells. J Pharmacol Exp Ther (1974) 1.40
Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr (1992) 1.40
Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant (1992) 1.40
Complicated PEG-to-skin level gastrostomy conversions: analysis of risk factors for tract disruption. Gastrointest Endosc (1996) 1.39
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology (2008) 1.36
Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol (1987) 1.34
A dominant influence of flanking sequences on a local structural transition in DNA. Cell (1986) 1.33
Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology (1986) 1.32
Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology (2003) 1.31
Glycolysis in quiescent cultures of 3T3 cells. Stimulation by serum, epidermal growth factor, and insulin in intact cells and persistence of the stimulation after cell homogenization. J Biol Chem (1978) 1.30
Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg (1995) 1.30
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol (1993) 1.28
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Blood (1996) 1.27
Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol (1997) 1.27
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant (1988) 1.27
Cystine accumulation and loss in normal, heterozygous, and cystinotic fibroblasts. Proc Natl Acad Sci U S A (1982) 1.26
Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis (1984) 1.26
Gender, cognitive decline, and risk of AD in older persons. Neurology (2003) 1.25
Progression of gait disorder and rigidity and risk of death in older persons. Neurology (2002) 1.25
Marrow harvesting from normal donors. Blood (1984) 1.25
Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol (1990) 1.24
Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH. J Cell Biol (1986) 1.24
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood (2001) 1.24
Neurologic and cognitive deficits in children with cystinosis. J Pediatr (1988) 1.22
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
Cystinotic fibroblasts accumulate cystine from intracellular protein degradation. Proc Natl Acad Sci U S A (1977) 1.22
Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology (1986) 1.21
Plug the lung until it grows (PLUG): a new method to treat congenital diaphragmatic hernia in utero. J Pediatr Surg (1994) 1.21
Growth and development following marrow transplantation for leukemia. Blood (1986) 1.20
Glycolysis of quiescent cultures of 3T3 cells. Addition of serum, epidermal growth factor, and insulin increases the activity of phosphofructokinase in a protein synthesis-independent manner. J Biol Chem (1978) 1.20